German China
Search

USA: Adenosine Triphosphate Measuring Agilent Launches Real-Time ATP Rate Assay Kit

| Editor: Alexander Stark

Agilent Technologies lauched the Agilent Seahorse XF Real-Time ATP Rate Assay Kit — a new product that will enable biologists to enhance their understanding of how live-cells function in real-time.

Related Company

The Seahorse XF Real-Time ATP Rate Assay Kit enables researchers to measure and quantify the rate at which cells produce adenosine triphosphate (ATP).
The Seahorse XF Real-Time ATP Rate Assay Kit enables researchers to measure and quantify the rate at which cells produce adenosine triphosphate (ATP).
(Source: Agilent)

Santa Clara/USA — The Seahorse XF Real-Time ATP Rate Assay Kit enables researchers to measure and quantify the rate at which cells produce adenosine triphosphate (ATP), a complex organic chemical that plays a role in many biological processes. According to the manufacturer, it is the only product available that can measure ATP production from both energy-producing pathways (mitochondrial respiration and glycolysis) simultaneously.

The new assay delivers unique insights into cell phenotype and function, providing a window into the critical activities driving cell signaling, proliferation, activation, toxicity, and biosynthesis. The assay expands the application range for XF technology — which can detect discrete changes in cell metabolism and bioenergetics, as they happen — providing physiologically relevant metrics, and is more informative than the traditional method of simply measuring the total, static, end-point level of cellular ATP.

The Seahorse XF Real-Time ATP Rate Assay is easy to run, utilizing convenient data processing tools, and features an optimized single-use format to reduce complexity and simplify the workflow. Agilent designed the kit to accelerate research in fields such as biochemistry, biotechnology, oncology, immunology, cell biology, molecular biology, neurosciences, genomics, proteomics, metabolomics, toxicology, and drug discovery.

(ID:45280912)